Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir (Q42176233)
Jump to navigation
Jump to search
scientific article published on 17 September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir |
scientific article published on 17 September 2009 |
Statements
1 reference
Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir (English)
1 reference
1 reference
Shalender Bhasin
1 reference
Wen Guo
1 reference
Siu Wong
1 reference
Jeffrey Pudney
1 reference
Ravi Jasuja
1 reference
Ning Hua
1 reference
Lan Jiang
1 reference
Andrew Miller
1 reference
Paul W Hruz
1 reference
17 September 2009
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference